Navigation Links
American Scientific Resources and School Health Corporation to Supply The Disintegrator™ Needle Destruction Device to Texas School District
Date:7/11/2011

BOCA RATON, Fla., July 11, 2011 /PRNewswire/ -- American Scientific Resources, Inc. ("American Scientific Resources" or the "Company") (OTCQB: ASFX) and its distributor, School Health Corporation, today announced that they have received a purchase order from School Health Corporation for 108 Disintegrator Plus units to be delivered to a single school district to meet their needle disposal needs.

(Logo: http://photos.prnewswire.com/prnh/20110124/NY34439LOGO)

The Disintegrator Plus™ is an FDA approved and EPA recommended needle destruction device for home use.  The Disintegrator Plus™ is a portable -needle destruction device that uses plasma arc technology to disintegrate the syringe's needle.  The device is powered by a small, 9.6 volt nickel metal hydride (NiMh) rechargeable battery and is RoHS compliant and has the quality assurance of the CE mark. The device is intended for 27-31 gauge insulin hypodermic needles that are 1/4 to 1/2 inch in length. It can be used with most insulin pens and with disposable insulin syringes from 1/3 to 1 cubic centimeter in volume. The used needle is inserted into a hole on the device and the power button is pressed for a few seconds. The battery produces an arc of electricity that melts and blunts the needle tip, kills pathogens and seals the syringe making it safe to throw directly into the household trash.  The action produces no smoke, ash or residue and there is nothing to clean out.  The Disintegrator Plus™ is a portable needle destruction device that serves as an effective alternative to conventional sharps containers for disposal of used needles for self injectors.

"People who rely on self-injection drugs for treatment, such as diabetics, persons with multiple sclerosis, kids on growth hormone, etc. are usually faced with the uncertainty of how to properly dispose of used syringes," said Christopher F. Tirotta, MD, Chairman and Chief Executive Officer of American S
'/>"/>

SOURCE American Scientific Resources, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
4. Aspirin Named 8th World Wonder by Majority of Americans
5. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
6. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
7. TrialCheck(R) Cancer Clinical Trial Matching Interface to Debut on American Cancer Society Web Site
8. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
9. Positive Results for NKTR-118 (oral PEG-naloxol) Presented at American Academy of Pain Management Meeting
10. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
11. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015 Gem Pharmaceuticals announced today that the ... into the Company,s Phase 2 clinical trial.  This open-label ... lead compound, GPX-150 (an investigational medication), in approximately 30 ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/22/2015)... , Jan. 22, 2015  ViewRay™, a privately held medical ... an exclusive distributor agreement with ITOCHU Corporation (Tokyo Stock ... system for the treatment of cancer in ... is the world,s first and only MRI-guided radiation therapy ...
(Date:1/22/2015)... Jan. 22, 2015  ResMed Inc. (NYSE: RMD ) ... Revenue for the quarter was $423.0 million, a 10 percent ... 14 percent increase on a constant currency basis). Net income ... the quarter ended December 31, 2013. Diluted earnings per share ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11
(Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce the release of ... kids with cancer. The Chemo Duck App, available on iTunes for ... games to help children of all ages living with cancer adjust ... kids entertained, educated and at ease while waiting for clinic visits ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota ... it means to “Live Fearless.” , The “Faces ... their stories about how they or someone they know has ... living in the moment. By telling these types of stories ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo ... the federal multidistrict litigation underway in U.S. District Court, ... an Order dated January 20th, the Court has remanded ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
(Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
... , KENILWORTH, N.J., Aug. 6 Schering-Plough Corporation ... its Special Shareholders Meeting being held on Friday, August 7, 2009, ... Merck & Co., Inc. Originating from Boston, the Webcast will ... www.schering-plough.com . , , Those ...
... ... Angelman Syndrome Foundation, www.angelman.org , announced the formation of the ... rapidly increasing research funding. The ATRI will also serve as a ... share discoveries and treatments for this neuro-genetic disorder. The announcement of ...
... NORTH BERGEN, N.J., Aug. 6 Vitamin Shoppe ... vitamins, minerals and nutritional products, will hold a conference call ... Eastern Time. During the call, members of management will ... , , To participate in the teleconference, ...
... , , , ... AIRM ), the largest air medical transportation company in the world, ... and provided an update on July 2009 flight volumes. For ... in the current-year quarter. For the six-month period, revenue increased ...
... EATONTOWN, N.J., Aug. 6 Osteotech, Inc. (Nasdaq: ... products for regenerative healing, announced today that its management team is ... Conference at the InterContinental Hotel in Boston on Thursday, August 13, ... live, listen-only webcast of the presentation will be available at the ...
... Study finds fewer than half always recommend the shots, ... News) -- More than half of Texas doctors don,t ... U.S. guidelines urging their inoculation, a new survey finds. ... cancer, and the national Advisory Committee on Immunization Practices ...
Cached Medicine News:Health News:Angelman Syndrome Foundation Takes Major Step Toward Furthering Research Efforts 2Health News:Angelman Syndrome Foundation Takes Major Step Toward Furthering Research Efforts 3Health News:Air Methods Reports 2Q2009 Results and 3Q2009 Update 2Health News:Air Methods Reports 2Q2009 Results and 3Q2009 Update 3Health News:Air Methods Reports 2Q2009 Results and 3Q2009 Update 4Health News:Air Methods Reports 2Q2009 Results and 3Q2009 Update 5Health News:Air Methods Reports 2Q2009 Results and 3Q2009 Update 6Health News:Air Methods Reports 2Q2009 Results and 3Q2009 Update 7Health News:Many Texas Docs Not Pushing HPV Vaccine for Girls 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: